Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$25M
1 round on record
Latest round
$25M
Series A · Dec 2022 · 3 yr ago
Team
1-10
employees, estimated range
Backers
1
Xontogeny
The money's age
Long since its last round
45 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Dec 2022 | $25M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Xontogeny Similar startupsby what they do, their industry and backers
Neurogastrx, Inc.. Thank you for visiting the website for Neurogastrx, Inc. ("Company"), a privately held, late clinical-stage…
About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes…
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of…
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies…
Treat Beyond the Clot.. Real-time data to guide clinical decisions when treating blood clots in the lungs.
Overview
Peroxitech is a privately held emerging biopharmaceutical company focused on the development and commercialization of a novel peptide for treating acute lung injury.
Financials
Total raised
$25M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2022 | $25M | Details |